Metraipolis › archive › dc_08a09e63c7ac
Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies? — Europe PMC PMID:41304766
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304766
- DOI
- 10.3390/pharmaceutics17111428
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:33:50.108Z
- SHA-256 of the archived text
f70208e656d6e0e6fd7ecc078bb1d2e14ddd23c0e496feeb05719d1194b829ad- Stable URL of this page
https://metraipolis.com/documento/dc_08a09e63c7ac
How to cite
Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies? — Europe PMC PMID:41304766 — Europe PMC (en), https://europepmc.org/article/MED/41304766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08a09e63c7ac (Metraipolis archive dc_08a09e63c7ac, sha256 f70208e656d6e0e6fd7ecc078bb1d2e14ddd23c0e496feeb05719d1194b829ad)
BibTeX
@misc{dc08a09e63c7ac,
title = {Targeting Drug-Tolerant Persister Cancer Cells: Can Nanomaterial-Based Strategies Be Helpful for Anti-DTP Therapies? — Europe PMC PMID:41304766},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304766},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08a09e63c7ac; sha256 f70208e656d6e0e6fd7ecc078bb1d2e14ddd23c0e496feeb05719d1194b829ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304766. Agents can read the archived copy with the MCP tool read_document.